Journal article icon

Journal article

Clinical management of community-acquired meningitis in adults in the UK and Ireland in 2017: a retrospective cohort study on behalf of the National Infection Trainees Collaborative for Audit and Research (NITCAR)

Abstract:
ObjectivesTo investigate whether there is a dose-dependent association between empiric dexamethasone and outcome in viral meningitis.MethodsObservational cohort study of adults hospitalized for viral meningitis, both with and without a microbiologically confirmed diagnosis, in Denmark between 2015 and 2020. Dose-dependent associations between dexamethasone (one dose = 10 mg) and an unfavourable outcome (Glasgow Outcome Scale score 1–4) at 30 days after discharge were assessed using weighted logistic regression. Entropy balancing was used to compute weights.ResultsOf 1025 included patients, 658 (64%) did not receive dexamethasone, 115 (11%) received 1–2 doses, 131 (13%) received 3–4 doses, and 121 (12%) received ≥5 doses. Among patients treated with dexamethasone, the median number of doses was higher for those without an identified pathogen than for those with a microbiologically confirmed viral aetiology (5 [interquartile range (IQR) 3–8] vs. 3 [IQR 2–5]; p < 0.001). Using no doses of dexamethasone as a reference, the weighted OR for an unfavourable outcome were 0.55 (95% CI, 0.29–1.07) for 1–2 doses, 1.13 (95% CI, 0.67–1.89) for 3–4 doses, and 1.43 (95% CI, 0.77–2.64) for ≥5 doses. In the subgroup of enteroviral meningitis, the weighted OR was 3.08 (95% CI, 1.36–6.94) for ≥5 doses, but decreased to 2.35 (95% CI, 0.65–8.40) when the reference group was restricted to patients treated with antibiotics for suspected bacterial meningitis.DiscussionThis study showed no dose-dependent association between dexamethasone and an unfavourable outcome in patients with viral meningitis. In enteroviral meningitis, ≥5 doses were associated with an increased risk of an unfavourable outcome. However, sensitivity analysis indicated that the association was affected by unmeasured or residual confounding by severity
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Authors

More by this author
Role:
Author
ORCID:
0000-0002-7009-9144
More by this author
Role:
Author
ORCID:
0000-0001-7333-1458
More by this author
Role:
Author
ORCID:
0000-0002-4729-7505
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-1313-7922


Publisher:
BMJ Publishing Group
Journal:
BMJ Open More from this journal
Volume:
12
Issue:
7
Pages:
e062698-e062698
Publication date:
2022-07-13
Acceptance date:
2022-06-01
DOI:
EISSN:
2044-6055
ISSN:
2044-6055


Language:
English
Keywords:
Pubs id:
1269081
Local pid:
pubs:1269081
Source identifiers:
W4285404998
Deposit date:
2026-04-27
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP